title: Novel cytochrome p450 bioactivation of a terminal phenyl acetylene group: formation of a one-carbon loss benzaldehyde and other oxidative products in the presence of N-acetyl cysteine or glutathione.
abstract: Compounds 1 (N1-(3-ethynylphenyl)-6-methyl-N5-(3-(6-(methylamino)pyrimidin-4-yl)pyridin-2-yl) isoquinoline-1,5-diamine) and 2 (N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine; Erlotinib/Tarceva) are kinase inhibitors that contain a terminal phenyl acetylene moiety. When incubated in the presence of P450 and NADPH, the anticipated phenyl acetic acid metabolite was formed. When 10 mM of N-acetyl-l-cysteine was added to the incubation mixtures, the phenyl acetic acid product was reduced and at 25 mM or higher concentration of NAC, formation of the phenyl acetic acid was abolished. Instead, the phenyl acetylene moiety lost a carbon and formed a benzaldehyde product. Other oxidation products incorporating one or more equivalents of NAC were also observed. The identities of the metabolites were characterized by MS and NMR. Addition of deferoxamine or ascorbic acid diminished the formation of the NAC influenced products. Similar products were also observed when 1 or 2 were incubated in P450 reactions supplemented with GSH, in Fenton reactions supplemented with NAC or GSH, and in peroxidase reactions supplemented with NAC. We propose the thiols act as a pro-oxidant readily undergoing a one-electron oxidation to form thiyl radicals which in turn initiates the formation of other peroxy radicals that drive the reaction to the observed products. These in vitro findings suggest that one-electron oxidation of thiols may promote the cooxidation of xenobiotic substrates.
authors.affiliation: Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, California 91320, United States. rajus@amgen.com
authors.forename: Raju
authors.initials: R
authors.lastname: Subramanian
authors.forename: Janet
authors.initials: J
authors.lastname: Tam
authors.forename: Divesh
authors.initials: D
authors.lastname: Aidasani
authors.forename: Darren L
authors.initials: DL
authors.lastname: Reid
authors.forename: Gary L
authors.initials: GL
authors.lastname: Skiles
mesh_terms: D000111:Acetylcysteine / Q000378:metabolism*; D000114:Acetylene / Q000378:metabolism*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001205:Ascorbic Acid / Q000494:pharmacology; D001547:Benzaldehydes / Q000378:metabolism*; D002417:Cattle; D002614:Chelating Agents / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D003676:Deferoxamine / Q000494:pharmacology; D004285:Dogs; D005978:Glutathione / Q000378:metabolism*; D006801:Humans; D008297:Male; D010084:Oxidation-Reduction; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000975:Antioxidants; D001547:Benzaldehydes; D002614:Chelating Agents; D003577:Cytochrome P-450 Enzyme System; D005978:Glutathione; D003676:Deferoxamine; D000114:Acetylene; D001205:Ascorbic Acid; C032175:benzaldehyde; D000111:Acetylcysteine